CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 0.880
- +0.030+3.53%
15min DelayMarket Closed Jul 12 15:19 ET
40.07MMarket Cap-4631P/E (TTM)
0.890High0.850Low124.61KVolume0.850Open0.850Pre Close106.71KTurnover3.04052wk High0.29%Turnover Ratio45.54MShares0.68052wk Low-0.19EPS TTM37.85MFloat Cap8.150Historical HighLossP/E (Static)43.01MShs Float0.680Historical Low-0.2EPS LYR4.71%Amplitude--Dividend TTM-17.60P/B1Lot Size--Div YieldTTM
Defence Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -2.56%1.21M | 334.29%8.31M | 27.13%2.11M | -25.95%1.24M | -1.44%1.91M | 8.72%1.66M | 156.02%7.32M | 28.91%2.17M | 142.81%1.68M | 338.90%1.94M |
| Selling and administrative expenses | -53.01%439.14K | 1,023.04%6.59M | 494.45%970.4K | 45.66%934.45K | -45.06%587.23K | -83.67%163.24K | 109.31%3.56M | -15.85%957.74K | 106.57%641.52K | 390.83%1.07M |
| -Selling and marketing expense | -73.34%205.19K | 101.62%514.25K | 720.17%853.71K | 50.21%769.52K | -61.05%255.06K | -88.06%104.09K | 640.00%2.52M | 63.38%485.02K | 97,478.67%512.29K | 1,398.02%654.78K |
| -General and administrative expense | 41.84%233.95K | 1,730.56%6.08M | 97.27%116.69K | 27.63%164.93K | -19.79%332.17K | -53.62%59.15K | -23.82%1.04M | -43.81%472.73K | -58.32%129.23K | 137.91%414.12K |
| Research and development costs | 148.67%641.86K | 25.93%1.57M | -27.36%1.06M | -73.88%258.12K | 42.72%1.24M | 173.92%1.45M | 224.58%3.76M | 150.51%1.37M | 159.95%988.3K | 288.52%872.15K |
| Depreciation amortization depletion | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --285 | --12.75K | --0 | ---- | ---- | --0 | --0 |
| -Depreciation and amortization | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --285 | --12.75K | --0 | ---- | ---- | --0 | --0 |
| Other operating expenses | 116.99%106.64K | 103.37%139.05K | 60.79%76.08K | 3.73%49.15K | --68.37K | --47.32K | ---- | ---- | --47.38K | ---- |
| Operating profit | 2.56%-1.21M | -334.29%-8.31M | -27.13%-2.11M | 25.95%-1.24M | 1.44%-1.91M | -8.72%-1.66M | -156.02%-7.32M | -28.91%-2.17M | -142.81%-1.68M | -338.90%-1.94M |
| Net non-operating interest income (expenses) | 8.34%-93.13K | -4.47%-53.32K | -80.91K | -101.6K | -51.04K | 0 | 0 | 0 | ||
| Non-operating interest income | -74.67%1.72K | --4.76K | --15.05K | --6.8K | --0 | --0 | ---- | ---- | --0 | ---- |
| Non-operating interest expense | -12.50%94.86K | 13.79%58.08K | --95.96K | --108.41K | --51.04K | --0 | ---- | ---- | --0 | --0 |
| Other net income (expenses) | -5,447.05%-24.44K | 274.76%41.75K | 95.83%-1.65K | 102.62%457 | -23.89K | -39.46K | -23.87K | -6.44K | -17.42K | |
| Gain on sale of security | -5,447.05%-24.44K | 274.76%41.75K | 95.83%-1.65K | 102.62%457 | ---23.89K | ---39.46K | ---23.87K | ---6.44K | ---17.42K | ---- |
| Income before tax | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Net income continuous operations | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Diluted earnings per share | 0.00%-0.03 | -280.00%-0.19 | 0.00%-0.05 | 40.00%-0.03 | 0.00%-0.05 | -25.00%-0.05 | -81.82%-0.2 | -25.43%-0.06 | -151.89%-0.05 | -293.42%-0.05 |
| Basic earnings per share | 0.00%-0.03 | -280.00%-0.19 | 0.00%-0.05 | 40.00%-0.03 | 0.00%-0.05 | -25.00%-0.05 | -81.82%-0.2 | -25.43%-0.06 | -151.89%-0.05 | -293.42%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg